|
Gabriele Costantino |
Innovative Medicines Joint Undertaking (IMI JU) 2009 Call for proposals
The official launch of the second call 2009 is to be held in Brussels, November 17th and the deadline for the expression of interest has been set to February 8, 2010. There will be as much as €76.8 million provided by the European Commission, plus at least the same amount mobilized by member companies of the European Federation of Pharmaceutical Industries and Associations (EFPIA)
The IMI 2009 Call for proposals will have 9 topics addressing two of the four strategic pillars identified by the IMI, namely Predictivity of Efficacy Evaluation and Knowledge Management.
The 9 topics are: (1) Oncology – Target Validation; (2) Oncology - Molecular Biomarkers; (3) Oncology – Imaging Biomarkers; (4) Infectious Diseases – Diagnostic Tools; (5) Inflammation – Aberrant Adaptive Immunity; (6) Inflammation – Translation Research; (7) Knowledge Management – Drug / Disease Modelling; (8) Knowledge Management – Open Pharmacological Space; (9) Knowledge Management - Electronic Health Records (HER)
Information and materials available at www.imi.europa.eu
By Gabriele Costantino
|
|
Editor
Gabriele Costantino Univ. Parma, IT
Editorial Committee
Erden Banoglu Gazi Univ., TR
Leonardo Scapozza Univ. of Geneve, CH
Wolfgang Sippl Univ. Halle-Wittenberg, DE
Kristian Stromgaard Univ. Copenhagen, DK
Mark Lansdell Pfizer, UK
Executive Committee
Gerhard Ecker President
Roberto Pellicciari Past-Pres.
Koen Augustyns Secretary
Rasmus P.Clausen Treasurer
Javier Fernandez Member
Mark Bunnage Member
Peter Matyus Member
|